Paid Clinical Trials Bowling Green
Discover 57 paid clinical trials in Bowling Green, Kentucky. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Chemotherapy with Endocrine TherapyEvaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Sponsor:
NRG Oncology
Location:
Code:
NCT05879926
Conditions
Breast Cancer
Eligibility Criteria
Sex: Female
Age: 18 - 60
Healthy Volunteers: Not accepted
Interventions
Ovarian Function Suppression + Aromatase Inhibitor
Adjuvant Chemotherapy + Ovarian Function Suppression
Ruxolitinib CreamA Study to Evaluate the Safety and Tolerability of Maximal Use Ruxolitinib Cream
Sponsor:
Incyte Corporation
Location:
Code:
NCT06213831
Conditions
Prurigo Nodularis
Eligibility Criteria
Sex: All
Age: 18 - 65
Healthy Volunteers: Not accepted
Interventions
Ruxolitinib Cream 1.5%
ZiltivekimabA Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation
Sponsor:
Novo Nordisk A/S
Location:
Code:
NCT05636176
Conditions
Heart Failure
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Ziltivekimab
Placebo
TAK-279A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis
Sponsor:
Takeda
Location:
Code:
NCT06550076
Conditions
Plaque Psoriasis
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
TAK-279
LasmiditanA 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine
Sponsor:
Eli Lilly and Company
Location:
Code:
NCT04396574
Conditions
Migraine
Eligibility Criteria
Sex: All
Age: 6 - 17
Healthy Volunteers: Not accepted
Interventions
Lasmiditan
Immunotherapy with ChemotherapyTesting the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-Small Cell Lung Cancer, ALCHEMIST Trial
Sponsor:
National Cancer Institute (NCI)
Location:
Code:
NCT04267848
Conditions
Lung Non-Small Cell Carcinoma
Lung Non-Small Cell Squamous Carcinoma
Lung Non-Squamous Non-Small Cell Carcinoma
Stage II Lung Cancer AJCC v8
Stage IIIA Lung Cancer AJCC v8
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Biospecimen Collection
Carboplatin
Cisplatin
Computed Tomography
Echocardiography Test
APG777A Study Evaluating APG777 in Atopic Dermatitis
Sponsor:
Apogee Therapeutics, Inc.
Location:
Code:
NCT06395948
Conditions
Atopic Dermatitis
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
APG777
Placebo
Ruxolitinib CreamA Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
Sponsor:
Incyte Corporation
Location:
Code:
NCT06548360
Conditions
NonSegmental Vitiligo
Eligibility Criteria
Sex: All
Age: 2 - 11
Healthy Volunteers: Not accepted
Interventions
Ruxolitinib Cream
Vehicle Cream
EltrekibartA Study of Eltrekibart (LY3041658) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
Sponsor:
Eli Lilly and Company
Location:
Code:
NCT06046729
Conditions
Hidradenitis Suppurativa
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Eltrekibart
Placebo
Upadacitinib vs. AdalimumabStudy to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis
Sponsor:
AbbVie
Location:
Code:
NCT05814627
Conditions
Rheumatoid Arthritis
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Upadacitinib
Adalimumab
Upadacitinib Matching Placebo
Adalimumab Matching Placebo